These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20553077)

  • 21. Anthropometric and behavioral correlates of insulin-like growth factor I and insulin-like growth factor binding protein 3 in middle-aged Japanese men.
    Teramukai S; Rohan T; Eguchi H; Oda T; Shinchi K; Kono S
    Am J Epidemiol; 2002 Aug; 156(4):344-8. PubMed ID: 12181104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum insulin-like growth factors, insulin-like growth factor-binding protein-3, and risk of lung cancer death: a case-control study nested in the Japan Collaborative Cohort (JACC) Study.
    Wakai K; Ito Y; Suzuki K; Tamakoshi A; Seki N; Ando M; Ozasa K; Watanabe Y; Kondo T; Nishino Y; Ohno Y;
    Jpn J Cancer Res; 2002 Dec; 93(12):1279-86. PubMed ID: 12495466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study.
    Drogan D; Schulze MB; Boeing H; Pischon T
    Am J Epidemiol; 2016 Mar; 183(6):553-60. PubMed ID: 26880678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nested case-control study of stomach cancer and serum insulin-like growth factor (IGF)-1, IGF-2 and IGF-binding protein (IGFBP)-3.
    Pham TM; Fujino Y; Kikuchi S; Tamakoshi A; Yatsuya H; Matsuda S; Yoshimura T;
    Eur J Cancer; 2007 Jul; 43(10):1611-6. PubMed ID: 17532620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction.
    Iglesias P; Bayón C; Méndez J; Gancedo PG; Grande C; Diez JJ
    Thyroid; 2001 Nov; 11(11):1043-8. PubMed ID: 11762714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-I and IGF binding protein-3 levels in Black and White men: the CARDIA Male Hormone Study.
    Gapstur SM; Kopp P; Chiu BC; Gann PH; Colangelo LA; Liu K
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2208-16. PubMed ID: 15598782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-Like Growth Factor-I, Insulin-Like Growth factor Binding Protein-3 and Blood Hemoglobin Concentration in an Elderly Population.
    Duron E; Vidal JS; Funalot B; Brunel N; Viollet C; Rigaud AS; Labourée F; Epelbaum J; le Bouc Y; Hanon O
    J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):854-9. PubMed ID: 25384548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum insulin-like growth factor-I levels among women in Hawaii and Japan with different levels of tofu intake.
    Takata Y; Maskarinec G; Rinaldi S; Kaaks R; Nagata C
    Nutr Cancer; 2006; 56(2):136-42. PubMed ID: 17474858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women.
    Gram IT; Norat T; Rinaldi S; Dossus L; Lukanova A; Téhard B; Clavel-Chapelon F; van Gils CH; van Noord PA; Peeters PH; Bueno-de-Mesquita HB; Nagel G; Linseisen J; Lahmann PH; Boeing H; Palli D; Sacerdote C; Panico S; Tumino R; Sieri S; Dorronsoro M; Quirós JR; Navarro CA; Barricarte A; Tormo MJ; González CA; Overvad K; Paaske Johnsen S; Olsen A; Tjønneland A; Travis R; Allen N; Bingham S; Khaw KT; Stattin P; Trichopoulou A; Kalapothaki V; Psaltopoulou T; Casagrande C; Riboli E; Kaaks R
    Int J Obes (Lond); 2006 Nov; 30(11):1623-31. PubMed ID: 16552400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH-suppressed Graves' disease.
    Wan Nazaimoon WM; Khalid BA
    Horm Metab Res; 1998 Apr; 30(4):213-6. PubMed ID: 9623636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
    Amin S; Riggs BL; Atkinson EJ; Oberg AL; Melton LJ; Khosla S
    J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women.
    Lukanova A; Toniolo P; Akhmedkhanov A; Biessy C; Haley NJ; Shore RE; Riboli E; Rinaldi S; Kaaks R
    Int J Cancer; 2001 Jun; 92(6):888-92. PubMed ID: 11351312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL; Elofsson S; Brismar K
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
    Gentili A; Mulligan T; Godschalk M; Clore J; Patrie J; Iranmanesh A; Veldhuis JD
    J Clin Endocrinol Metab; 2002 Feb; 87(2):825-34. PubMed ID: 11836328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study.
    Wolk A; Mantzoros CS; Andersson SO; Bergström R; Signorello LB; Lagiou P; Adami HO; Trichopoulos D
    J Natl Cancer Inst; 1998 Jun; 90(12):911-5. PubMed ID: 9637140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.